Used as a selective inhibitor of phosphodiesterase 10A (PDE10A), this compound is primarily employed in neuroscience research to study signaling pathways related to dopamine regulation. It helps investigate the role of PDE10A in psychiatric and neurological disorders such as schizophrenia, Huntington's disease, and Parkinson's disease. Due to its ability to modulate cyclic nucleotide levels in the brain, it serves as a tool compound for evaluating potential antipsychotic effects and striatal function in preclinical models. Its application remains confined to laboratory and experimental settings, with no current clinical use in humans.